Oslo - Delayed Quote NOK

Medistim ASA (MEDI.OL)

207.00
-4.00
(-1.90%)
At close: June 6 at 4:25:12 PM GMT+2
Currency in NOK All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
603,923
556,164
521,109
486,262
417,817
Cost of Revenue
119,266
113,680
112,280
106,486
97,114
Gross Profit
484,657
442,484
408,829
379,776
320,703
Operating Expense
326,479
311,409
277,402
238,527
204,428
Operating Income
158,178
131,075
131,427
141,249
116,275
Net Non Operating Interest Income Expense
3,742
4,801
2,839
1,734
-402
Pretax Income
160,292
134,246
135,212
146,049
114,071
Tax Provision
37,415
30,414
31,389
32,077
23,171
Net Income Common Stockholders
122,877
103,832
103,823
113,973
90,900
Diluted NI Available to Com Stockholders
122,877
103,832
103,823
113,973
90,900
Basic EPS
6.71
5.67
5.68
6.25
4.99
Diluted EPS
6.71
5.67
5.67
6.24
4.98
Basic Average Shares
18,314.22
18,314.22
18,267.16
18,248
18,215.94
Diluted Average Shares
18,314.22
18,314.22
18,296.16
18,277
18,249
Total Operating Income as Reported
158,181
131,076
131,442
141,251
116,278
Total Expenses
445,745
425,089
389,682
345,013
301,542
Net Income from Continuing & Discontinued Operation
122,877
103,832
103,823
113,973
90,900
Normalized Income
122,877
103,832
103,823
113,973
90,900
Interest Income
4,325
4,569
3,275
920
16
Interest Expense
6,639
490
151
123
178
Net Interest Income
3,742
4,801
2,839
1,734
-402
EBIT
157,936
131,075
131,427
146,172
114,249
EBITDA
181,679
155,585
155,097
169,460
137,676
Reconciled Cost of Revenue
119,266
113,680
112,280
106,486
97,114
Reconciled Depreciation
23,642
24,510
23,657
23,288
23,427
Net Income from Continuing Operation Net Minority Interest
122,877
103,832
103,823
113,973
90,900
Normalized EBITDA
181,679
155,585
155,097
169,460
137,676
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 5/28/2004

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CRAD-B.ST C-Rad AB (publ)
34.20
+0.44%
 
CEVI.ST CellaVision AB (publ)
197.40
+1.75%
 
MCAP.ST MedCap AB (publ)
437.50
-0.79%
 
PAX.ST Paxman AB (publ)
82.60
-1.20%
 
VITR.ST Vitrolife AB (publ)
156.50
-0.57%
 
ELN.MI EL.En. S.p.A.
10.75
-0.19%
 
SECT-B.ST Sectra AB (publ)
353.80
-0.28%
 
CHEMM.CO ChemoMetec A/S
523.00
-0.57%
 
DEMANT.CO Demant A/S
272.00
+6.75%
 
BRKR Bruker Corporation
38.30
+1.62%